BioLineRx Ltd (BLRX) — Cash Flow Reinvestment Rate

Latest as of December 2023: 4.09x

BioLineRx Ltd (BLRX) has a Cash Flow Reinvestment Rate of 4.09x as of December 2023, reinvesting $20.41 Million (capex $18.00K plus investments $-20.39 Million) from operating cash flow of $4.99 Million. Check BLRX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.09x
(Capex + Investments) / Operating CF

Total Reinvested

$20.41 Million
Capex + Investments

Operating Cash Flow

$4.99 Million
USD

Capital Expenditures

$18.00K
USD

BioLineRx Ltd Cash Flow Reinvestment Rate (2010–2010)

Historical reinvestment intensity for BioLineRx Ltd across 1 annual periods. Explore BioLineRx Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for BioLineRx Ltd (2010–2010)

Year-by-year capital reinvestment analysis for BioLineRx Ltd. For live market cap and broader valuation context, see how much is BioLineRx Ltd worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2010 0.06x $660.94K $11.46 Million $660.94K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow